Search results
Results from the WOW.Com Content Network
Tip #3: BrainHQ is all about giving your brain a full workout. Although the exercise categories described above are distinct, they rely on one another to work properly, explains Dr. Merzenich.
It makes people feel happier, healthier, and more in control of their lives. While most brain games lack any proof of effectiveness, BrainHQ’s benefits have been shown in hundreds of clinical ...
It takes a lot of brainpower to create BrainHQ’s brain training program.And much of that belongs to one man: Michael Merzenich, Ph.D., a professor emeritus at University of California San ...
Furthermore, the presence of autism can make it harder to diagnose coexisting psychiatric disorders such as depression. [9] Diagnosing will be much harder in adults, since most people with ASD who reach adulthood undiagnosed, learn diverse (and often intense) masking techniques which make external diagnosis almost impossible.
The autism-spectrum quotient (AQ) is a questionnaire published in 2001 by Simon Baron-Cohen and his colleagues at the Autism Research Centre in Cambridge, UK.Consisting of fifty questions, it aims to investigate whether adults of average intelligence (defined as an IQ of 80 or higher by the questionnaire) have symptoms of autism spectrum conditions. [1]
This poses a challenge to psychiatrists in identifying undiagnosed adults who may have autism. [2] Adults are being referred or self referred for diagnosis with increasing frequency, making this a useful clinical tool. [3] A score of 64 or more has been shown to be consistent and support a clinical diagnosis, but in the case the clinical ...
Other studies have found that BrainHQ training helps people step on the brakes more quickly when they need to, and make fewer dangerous maneuvers while driving. BrainHQ benefit #3: You can improve ...
Posit Science Corporation is an American company providing brain training software and services. [1] [2]Originally known as Neuroscience Solutions Corporation, the company was founded in 2002 by neuroscientists Michael Merzenich and Henry Mahncke, who originally intended to help people with schizophrenia. [3]